Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas

Pancreas

Volumn 12, Issue 3, 1996, Pages 248-259

  Löhr, Matthias ^a   Trautmann, Birgit ^b   Göttler, Martin ^b   Peters, Stephanie ^b   Zauner, Ira ^b   Maier, Anja ^b   Klöppel, Günter ^c   Liebe, Stefan ^a   Kreuser, Ernst Dieter ^d  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Extracellular matrix proteins; Immunohistology; Integrins; Pancreatic ductal adenocarcinoma; RNA expression

Indexed keywords

INTEGRIN; MATRIX PROTEIN;

ADENOCARCINOMA; ARTICLE; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0029940924     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199604000-00007     Document Type: Article

References (56)

1. Klöppel G, Fitzgerald PJ. Pathology of nonendocrine pancreatic tumors. In: Go VLW, Gardner JD, Brooks FP, Lebenthal E, DiMagno EP, Scheele GA, eds. The exocrine pancreas. Biology, pathobiology, and diseases. New York: Raven Press, 1986:649-74.
2. Klöppel G, Lingenthal G, Bülow Mv, Kern HF. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinicohistopathological correlation in a series of 75 cases. Histopathology 1985;9:841-56.
3. Ruoslahti E, Noble NA, Kagami S, Border WA. Integrins. Kidney Int 1994;45:17-22.
4. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992;69:11-25.
5. Golosow N, Grobstein C. Epitheliomesenchymal interactions in pancreatic morphogenesis. Dev Biol 1962;4:242-55.
6. Löhr M, Trautmann B. Pancreatic cancer: stromal-epithelial interactions. Int J Pancreatol 1993;14:57-8.
7. Ingber DE, Madri JA, Jamieson JD. Basement menbrane as a spatial organizer of polarized epithelia. Am J Pathol 1986; 122:129-39.
8. Hall PA, Coates PJ, Del Bruno R, et al. Patterns of cellular differentiation in human fetal, adult and pathological exocrine pancreas: correlation with in vitro and xenografted studies. J Pathol 1990;161:339a (abstract).
9. Löhr M, Trautmann B, Göttler M, et al. Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. Br J Cancer 1994;69:144-51.
10. Haglund C, Roberts PJ, Nordling S. Expression of laminin in benign and malignant sclerosing lesions of extrahepatic bile ducts. J Clin Pathol 1989;42:927-30.
11. Haglund C, Roberts PJ, Nordling S, Ekblom P. Expression of laminin in pancreatic neoplasms and in chronic pancreatitis. Am J Surg Pathol 1984;8:669-76.
12. Alitalo K, Keski-Oja J, Vaheri A. Extracellular matrix proteins characterize human tumor cell lines. Int J Cancer 1981; 27:755-61.
13. Haberern-Blood C, Liotta LA, Rao CN, Kupchik HZ. Laminin expression by human pancreatic carcinoma cells in the nude mouse and in culture. J Natl Cancer Inst 1987;79: 891-8.
14. Mahlbacher V, Sewing A, Elsässer HP, Kern HF. Hyaluran is a secretory product of human pancreatic adenocarcinoma cells. Eur J Cell Biol 1992;58:28-34.
15. Kern HF, Röher HD, von Bülow M, Klöppel G. Fine structure of three major grades of malignancy of human pancreatic adenocarcinoma. Pancreas 1987;2:2-13.
16. Kern HF, Rausch U, Mollenhauer J. Fine structure of human pancreatic adenocarcinoma. In: Go VLW, Gardner JD, Brooks FP, Lebenthal E, DiMagno EP, Scheele GA, eds. The exocrine pancreas. Biology, pathobiology, and diseases. New York: Raven Press, 1986:637-47.
17. Mai M, Brune K, Jacoby B, Kern HF, Mollenhauer J. Laminin interactions with ductal pancreatic adenocarcinoma cells: identification of laminin- and collagen-binding proteins. J Cell Sci 1990;95:65-74.
18. Hall PA, Coates P, Lemoine NR, Horton MA. Characterization of integrin chains in normal and neoplastic human pancreas. J Pathol 1991;165:33-41.
19. Rosendahl A, Neumann K, Chaloupka B, Rothmund M, Weinel R. Expression and distribution of VLA receptors in the pancreas: an immunohistochemical study. Pancreas 1993;8:711-8.
20. Kyriazis AP, Kyriazis AA, Scarpelli DG, Fogh J, Rao MS, Lepera R. Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse. Am J Pathol 1982;106: 250-60.
21. Haberern CL, Kupchik HZ. Diversity of adhesion to basement components of human pancreatic adenocarcinomas. Cancer Res 1985;45:5246-51.
22. Liehr RM, Melnykovych G, Solomon TE. Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2. Gastroenterology 1990;98:1666-74.
23. Trautmann B, Schutt HJ, Hahn EG, Löhr M. Isolation, culture, and characterization of human pancreatic duct cells. Pancreas 1993;8:248-54.
24. Rafiee P, Ho SB, Bresalier RS, Bloom EJ, Kim JH, Kim YS. Characterization of the cytokeratins of human colonie, pancreatic, and gastric adenocarcinoma cell lines. Pancreas 1992;7:123-31.
25. Giovanella BC, Fogh J. The nude mouse in cancer research. Adv Cancer Res 1985;44:69-120.
26. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
27. Löhr M, Oldstone MBA. Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes. Lancet 1990;336:644-8.
28. Petermann A, Fees H, Grenz H, Goodman S, Sterzel RB. Polymerase chain reaction and focal contact formation indicate integrin expression in mesangial cells. Kidney Int 1993; 44:997-1005.
29. x) is responsible for distinct adhesive properties of carcinoma cells. Cell 1989;57:59-69.
30. Lipkin WI, Battenberg ELF, Bloom FE, Oldstone MBA. Viral infection of neurons can depress neurotransmitter mRNA levels without histologic injury. Brain Res 1988;451: 333-9.
31. Heinze H, Arnold HH, Fischer D, Kruppa J. The primary structure of the human ribosomal protein S6 derived from a cloned cDNA. J Biol Chem 1988;263:4139-44.
32. Feinberg P, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13.
33. Hemler ME, Crouse C, Sonnenberg A. Association of the VLA α6 subunit with a novel protein. J Biol Chem 1989;264: 6529-35.
34. Johnson GD, de Nogueira Aranjo GM. A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods 1981;43:349-50.
35. Herzberg F, Schöning M, Lang P, Mücke C, Thiel E, Kreuser ED. IL-4 is a potent regulator of integrin expression. In: Abraham NG, Schaddock RK, Levine AS, Takaku S, eds. Molecular biology of hematopoesis, vol. 3. Hampshire, UK: Intercept Ltd., 1993:43-53.
36. Landegren U. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 1984;67:379-88.
37. Hay ED. Cell and extracellular matrix: their organization and mutual dependence. Modern Cell Biol 1983;2:509-48.
38. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol 1982;99:31-68.
39. Klöppel G. Immunocytochemical tumour markers in neoplasms of the gut, pancreas, and liver. In: Klapdor R, Greten H, eds. New tumour markers and their monoclonal antibodies. Stuttgart: Thieme, 1987:304-14.
40. Chen YF, Pan GZ, Hou X, et al. Epidermal growth factor and its receptor in human pancreatic carcinoma. Pancreas 1990;5:278-83.
41. Lemoine NR, Hughes CM, Barton CM, et al. The epidermal growth factor receptor in human pancreatic cancer. J Pathol 1992;166:7-12.
42. Ruoslahti E. Integrins. J Clin Invest 1991;87:1-5.
43. Pignatelli M, Smith MEF, Bodmer WF. Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. Br J Cancer 1990;61:636-8.
44. Weinel RJ, Rosendahl A, Neumann K, et al. Expression and function of VLA-α3, -α5 and α6 integrin receptors in pancreatic carcinoma. Int J Cancer 1992;52:827-33.
45. Cleutjens JPM, Havenith MG, Beek C, Vallinga M, Ten Kate J, Bosman FT. Origin of basement membrane type IV collagen in xenografted human epithelial tumor cell lines. Am J Pathol 1990;136:1165-72.
46. Damjanov I, Damjanov N, Knowles BB, Engvall E. Origin of laminin in the extracellular matrix of human tumor xenografts in nude mice. Virchows Arch B (Cell Pathol) 1985; 49:45-52.
47. Fingerman E, Hemler ME. Regulation of proteins in the VLA cell substrate adhesion family: influence of cell growth conditions on VLA-1, VLA-2, and VLA-3 expression. Exp Cell Res 1988;177:132-42.
48. Longnecker DS, Jamieson JD, Asch HL. Regulation of growth and differentiation in pancreatic cancer (conference report). Pancreas 1989;4:256-75.
49. Korc M. Growth factors and pancreatic cancer. Int J Pancreatol 1991;9:87-91.
50. Lemoine NR, Hall PA. Growth factors and oncogenes in pancreatic cancer. Baillieres Clin Gastroenterol 1990;4:815-32.
51. Kalthoff H, Roeder C, Humburg I, Thiele HG, Greten H, Schmiegel W. Modulation of platelet-derived growth factor A- and B-chain/c-sis mRNA by tumor necrosis factor and other agents in adenocarcinoma cells. Oncogene 1991;6: 1015-21.
52. Grinnell F. Wound repair, keratinocyte activation and integrin modulation. J Cell Sci 1992;101:1-5.
53. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987;48:549-54.
54. Stallmach A, Lampe Bv, Orzechowski HD, Riecken EO. Der Verlust der Fibronektinrezeptorexpression während der malignen Transformation im Kolon resultiert in einer gesteigerten Tumorigenität von Epithelzellen. Med Klinik 1993;88:175-80.
55. Singer II. The fibronexus: a transmembrane association of fibronectin-containing fibers and bundles of 5 nm microfilaments in hamster and human fibroblasts. Cell 1979;16:675-85.
56. Alberts B. The cytoskeleton. In: Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD, eds. Molecular biology of the cell. New York: Garland, 1989:613-80.